Affinity Asset Advisors, LLC Innate Pharma Sa Transaction History
Affinity Asset Advisors, LLC
- $560 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding IPHA
# of Institutions
10Shares Held
138KCall Options Held
0Put Options Held
0-
Exchange Traded Concepts, LLC77.4KShares$152,3790.0% of portfolio
-
Morgan Stanley New York, NY43.5KShares$85,7420.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il11.9KShares$23,3500.0% of portfolio
-
Ubs Group Ag3.51KShares$6,9140.0% of portfolio
-
Rhumbline Advisers Boston, MA675Shares$1,3290.0% of portfolio
About Innate Pharma SA
- Ticker IPHA
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,893,000
- Market Cap $157M
- Description
- Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and periphera...